Inovio Pharmaceuticals Inc (INO)

[MiamiGent]

Buyout? This is so FOS.
1. Inovio has nothing of value to buy- not one approved product originated in 43 years.
2. Nothing (0) promising in Phase Three trials.
3. A decidedly poor reputation. It's not for nothing Roche dropped Inovio before Inovio could take its coat off. And the Department of Defense said goodbye. And others.
4. The long-time de facto leader of Inovio, penny stock promoter Avtar Dhillon, is awaiting trial in Boston for multiple counts of stock fraud for other penny stock scams he was involved in. Dirty Dhillon was one of Inovio's Founders, an Inovio President, Inovio CEO, Inovio Director, and Inovio Chairman & highly Paid Consultant to Inovio to 2019.
5. INO is a penny stock, currently valued at .11 (eleven cents), when the most recent two Reverse Splits are accounted for.
6. No Big Pharma would taint their company.

Stop with promotions to lure in newbees to profit on their gullibility. Learn to trade, not dupe!

MG
Father of The Inovio Scam Expose